Infinx
AI and human-assisted platform for prior authorization and revenue cycle.
Infinx combines generative AI, machine learning, and human expertise for patient access and RCM, with a focus on prior authorization, claims management, and eligibility verification.
Editorial scorecard
Accuracy
Reliability of claims, output quality, and evidence fit.
Workflow fit
Fit for clinical, revenue, or operations workflows.
Compliance
HIPAA, PHI, BAA, and governance readiness signals.
Price-to-value
Value relative to expected cost, onboarding, and effort.
Vendor stability
Maturity, documentation, support, and market signals.
Introduction
This review has not published a long-form introduction yet.
Pros
- Strong prior-authorization automation (acquired Glidian)
- HITRUST i1 certification for defined scope
- Combines AI agents with human review
Cons
- Pricing opaque
- Blended AI/human model varies by service
- Certification scope is defined, not blanket
Pricing
Not publicly listed.
Compliance review
HIPAA
Confirmed
BAA
Not reviewed
Confirm the HITRUST scope, BAA terms, prior authorization decision boundaries, PHI access, audit logs, and how human teams supervise AI-assisted work.
Questions to ask before a demo
Use these questions to turn this profile into a buyer-side evidence checklist. HealthAIdir does not verify production readiness, clinical safety, compliance approval, coding accuracy, billing accuracy, or legal suitability.
- 1
Which healthcare workflow does Infinx support best?
Ask the vendor to map supported users, handoffs, review steps, and failure modes to your clinical, revenue cycle, or operations workflow.
- 2
What evidence should be reviewed before a pilot?
Request source documentation, validation notes, customer scope, update history, and implementation assumptions rather than relying on marketing claims.
- 3
How should the compliance and data handling claims be verified?
Confirm PHI flow, BAA availability, privacy terms, security controls, audit logs, subprocessors, and whether claims are contractual or only descriptive.
- 4
What integration and implementation work is required?
Clarify EHR, billing, identity, data export, monitoring, support ownership, training, timeline, and rollback requirements.
- 5
What pricing, contract, and pilot success criteria should be confirmed?
Review pricing unit, minimum commitments, renewal terms, cancellation, support scope, measurable pilot outcomes, and buyer-side responsibilities.
Related research
Continue researching Infinx.
Use explicit comparisons and alternative tool profiles to keep shortlist research connected to source evidence.
Candid Health vs Infinx
Compare Infinx with Candid Health: RCM automation platform that maximizes first-pass touchless claim rates.
AKASA vs Infinx
Compare Infinx with AKASA: Generative AI for healthcare revenue cycle operations.
Revenue Cycle
AI tools for medical billing, coding, claims, denials, and revenue cycle workflows.
RCM
Revenue cycle management workflows and automation.
Prior Authorization
Authorization workflows between providers and payers.
Run the healthcare AI procurement checklist
Convert profile findings into a vendor due diligence checklist.
Information
- Reviewed byHealthAIdir Editorial Team
- Websitewww.infinx.com
- Published2026/06/09
- Last reviewed2026/06/11
- VerdictConditional
Compliance snapshot
- HIPAAConfirmed
- BAANot reviewed
- Editorial disclosure
HealthAIdir used vendor public materials for this seed profile. No vendor paid for placement, and buyers should verify all compliance, pricing, and implementation claims directly with Infinx.
- Editorial boundary
Featured or sponsor placement does not affect HealthAIdir scores, verdicts, comparisons, or editorial recommendations.
Evidence and sources
Evidence links summarize public source material for traceability. They are not medical, billing, security, HIPAA, BAA, or compliance approval.
Infinx official site describes AI-plus-human prior authorization and RCM automation; a 2026 release notes HITRUST i1 certification for a defined scope.
Updated 44 days ago from a recorded review event (2026/06/11).